{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.","slug":"building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d","published_at":"2026-05-11T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19136686-building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19136686-building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO at Infinimmune, talks about how single-cell biology and computational rigor led to the formation of Infinimmune, and a new way to discover human-derived antibody drugs. Wyatt explains Infinimmune's 'discovered in humans' antibody discovery platform, how the company was launched and initially funded, and how Infinimmune landed a Merck collaboratio...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO at Inf…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3252,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}